Real-time enrollment status for this primary immunodeficiency disorders clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:43 AM UTC
| NCT Number | NCT03394053 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiency Disorders |
| Phase | Clinical Trial |
| Target Enrollment | 2,500 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT03394053 is currently recruiting participants. This clinical trial study for primary immunodeficiency disorders is actively seeking new participants at 2 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03394053 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03394053 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.